상세 보기
DREAMM-7 Study of Belantamab Mafodotin Plus Bortezomib and Dexamethasone vs Daratumumab Plus Bortezomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma: A Subgroup Analysis in Patients With High-Risk Cytogenetic Features
- Mateos, Maria Victoria;
- Robak, Pawel;
- Hus, Marek;
- Fu, Chengcheng;
- Zherebtsova, Vera;
- ... Kim, Kihyun;
- 외 13명
Citations
WEB OF SCIENCE
0키워드
MM; multiple myeloma; antibody-drug conjugate; belantamab mafodotin; DREAMM-7
- 제목
- DREAMM-7 Study of Belantamab Mafodotin Plus Bortezomib and Dexamethasone vs Daratumumab Plus Bortezomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma: A Subgroup Analysis in Patients With High-Risk Cytogenetic Features
- 저자
- Mateos, Maria Victoria; Robak, Pawel; Hus, Marek; Fu, Chengcheng; Zherebtsova, Vera; Ward, Christopher; Ho, P. Joy; Hajek, Roman; Kim, Kihyun; Dimopoulos, Meletios; Cerchione, Claudio; Pirooz, Nick; McKeown, Astrid; Lin, Chee Paul; Baig, Hena; Eccersley, Lydia; Roy-Ghanta, Sumita; Opa, Joanna; Hungria, Vania
- 발행일
- 2025-09
- 유형
- Meeting Abstract
- 권
- 25